132 related articles for article (PubMed ID: 38894576)
1. Growth hormone treatment for neurologic symptoms of post-acute sequelae of COVID-19.
Wright TJ; Sheffield-Moore M; Pyles RB; Randolph KM; McGovern KA; Danesi CP; Lindsay SE; Zaidan MF; Masel BE; Urban RJ
Clin Transl Sci; 2024 Jun; 17(6):e13826. PubMed ID: 38894576
[TBL] [Abstract][Full Text] [Related]
2. Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection (PASC) neurologic symptoms: A case-control pilot study.
Wright TJ; Pyles RB; Sheffield-Moore M; Deer RR; Randolph KM; McGovern KA; Danesi CP; Gilkison CR; Ward WW; Vargas JA; Armstrong PA; Lindsay SE; Zaidan MF; Seashore J; Wexler TL; Masel BE; Urban RJ
Mol Cell Endocrinol; 2024 Jan; 579():112071. PubMed ID: 37816478
[TBL] [Abstract][Full Text] [Related]
3. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
[TBL] [Abstract][Full Text] [Related]
4. Health-Related Quality of Life for Patients with Post-Acute COVID-19 Syndrome: Identification of Symptom Clusters and Predictors of Long-Term Outcomes.
Lapin B; Li Y; Englund K; Katzan IL
J Gen Intern Med; 2024 Jun; 39(8):1301-1309. PubMed ID: 38424349
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for growth hormone replacement in adults to control acute and post-acute COVID-19?
Venugopal N; Armstrong PA; Wright TJ; Randolph KM; Batson RD; Yuen KCJ; Masel B; Sheffield-Moore M; Pyles RB; Urban RJ
Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101842. PubMed ID: 37996257
[TBL] [Abstract][Full Text] [Related]
6. Growth Hormone Alters Brain Morphometry, Connectivity, and Behavior in Subjects with Fatigue after Mild Traumatic Brain Injury.
Wright T; Urban R; Durham W; Dillon EL; Randolph KM; Danesi C; Gilkison C; Karmonik C; Zgaljardic DJ; Masel B; Bishop J; Pyles R; Seidler R; Hierholzer AH; Sheffield-Moore M
J Neurotrauma; 2020 Apr; 37(8):1052-1066. PubMed ID: 31797721
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
[TBL] [Abstract][Full Text] [Related]
8. Chronic Disease Self-Management of Post-Acute Sequelae of COVID-19 Among Older Adults: A Mixed-Methods Analysis.
Thomas-Purcell K; Davenport R; Ayala V; Purcell D; Ownby RL
Clin Interv Aging; 2023; 18():607-617. PubMed ID: 37082741
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms.
Shanley JE; Valenciano AF; Timmons G; Miner AE; Kakarla V; Rempe T; Yang JH; Gooding A; Norman MA; Banks SJ; Ritter ML; Ellis RJ; Horton L; Graves JS
Ann Clin Transl Neurol; 2022 Jul; 9(7):995-1010. PubMed ID: 35702954
[TBL] [Abstract][Full Text] [Related]
10. Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients.
Nasrullah A; Virk S; Javed A; Shah A; Ramanujam D; Sharma A; Gutierrez L; Nauer K; Maggio M; Yin Y; Bajwa Y; Cheema T; Disilvio B
BMC Pulm Med; 2024 May; 24(1):231. PubMed ID: 38745298
[TBL] [Abstract][Full Text] [Related]
11. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
Thaweethai T; Jolley SE; Karlson EW; Levitan EB; Levy B; McComsey GA; McCorkell L; Nadkarni GN; Parthasarathy S; Singh U; Walker TA; Selvaggi CA; Shinnick DJ; Schulte CCM; Atchley-Challenner R; Alba GA; Alicic R; Altman N; Anglin K; Argueta U; Ashktorab H; Baslet G; Bassett IV; Bateman L; Bedi B; Bhattacharyya S; Bind MA; Blomkalns AL; Bonilla H; Brim H; Bush PA; Castro M; Chan J; Charney AW; Chen P; Chibnik LB; Chu HY; Clifton RG; Costantine MM; Cribbs SK; Davila Nieves SI; Deeks SG; Duven A; Emery IF; Erdmann N; Erlandson KM; Ernst KC; Farah-Abraham R; Farner CE; Feuerriegel EM; Fleurimont J; Fonseca V; Franko N; Gainer V; Gander JC; Gardner EM; Geng LN; Gibson KS; Go M; Goldman JD; Grebe H; Greenway FL; Habli M; Hafner J; Han JE; Hanson KA; Heath J; Hernandez C; Hess R; Hodder SL; Hoffman MK; Hoover SE; Huang B; Hughes BL; Jagannathan P; John J; Jordan MR; Katz SD; Kaufman ES; Kelly JD; Kelly SW; Kemp MM; Kirwan JP; Klein JD; Knox KS; Krishnan JA; Kumar A; Laiyemo AO; Lambert AA; Lanca M; Lee-Iannotti JK; Logarbo BP; Longo MT; Luciano CA; Lutrick K; Maley JH; Mallett G; Marathe JG; Marconi V; Marshall GD; Martin CF; Matusov Y; Mehari A; Mendez-Figueroa H; Mermelstein R; Metz TD; Morse R; Mosier J; Mouchati C; Mullington J; Murphy SN; Neuman RB; Nikolich JZ; Ofotokun I; Ojemakinde E; Palatnik A; Palomares K; Parimon T; Parry S; Patterson JE; Patterson TF; Patzer RE; Peluso MJ; Pemu P; Pettker CM; Plunkett BA; Pogreba-Brown K; Poppas A; Quigley JG; Reddy U; Reece R; Reeder H; Reeves WB; Reiman EM; Rischard F; Rosand J; Rouse DJ; Ruff A; Saade G; Sandoval GJ; Santana JL; Schlater SM; Sciurba FC; Shepherd F; Sherif ZA; Simhan H; Singer NG; Skupski DW; Sowles A; Sparks JA; Sukhera FI; Taylor BS; Teunis L; Thomas RJ; Thorp JM; Thuluvath P; Ticotsky A; Tita AT; Tuttle KR; Urdaneta AE; Valdivieso D; VanWagoner TM; Vasey A; Verduzco-Gutierrez M; Wallace ZS; Ward HD; Warren DE; Weiner SJ; Welch S; Whiteheart SW; Wiley Z; Wisnivesky JP; Yee LM; Zisis S; Horwitz LI; Foulkes AS;
JAMA; 2023 Jun; 329(22):1934-1946. PubMed ID: 37278994
[TBL] [Abstract][Full Text] [Related]
12. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.
Wallymahmed ME; Foy P; Shaw D; Hutcheon R; Edwards RH; MacFarlane IA
Clin Endocrinol (Oxf); 1997 Oct; 47(4):439-46. PubMed ID: 9404442
[TBL] [Abstract][Full Text] [Related]
13. Functional Changes after Recombinant Human Growth Hormone Replacement in Patients with Chronic Traumatic Brain Injury and Abnormal Growth Hormone Secretion.
Mossberg KA; Durham WJ; Zgaljardic DJ; Gilkison CR; Danesi CP; Sheffield-Moore M; Masel BE; Urban RJ
J Neurotrauma; 2017 Feb; 34(4):845-852. PubMed ID: 27627580
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC).
Santana K; França E; Sato J; Silva A; Queiroz M; de Farias J; Rodrigues D; Souza I; Ribeiro V; Caparelli-Dáquer E; Teixeira AL; Charvet L; Datta A; Bikson M; Andrade S
Brain Stimul; 2023; 16(1):100-107. PubMed ID: 36693536
[TBL] [Abstract][Full Text] [Related]
15. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
Höybye C; Thorén M; Böhm B
J Intellect Disabil Res; 2005 Apr; 49(Pt 4):245-52. PubMed ID: 15816811
[TBL] [Abstract][Full Text] [Related]
16. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
17. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
18. Association of Obstructive Sleep Apnea with Post-Acute Sequelae of SARS-CoV-2 Infection.
Quan SF; Weaver MD; Czeisler MÉ; Barger LK; Booker LA; Howard ME; Jackson ML; Lane RI; McDonald CF; Ridgers A; Robbins R; Varma P; Wiley JF; Rajaratnam SMW; Czeisler CA
Am J Med; 2024 Jun; 137(6):529-537.e3. PubMed ID: 38401674
[TBL] [Abstract][Full Text] [Related]
19. RECOVER-NEURO: study protocol for a multi-center, multi-arm, phase 2, randomized, active comparator trial evaluating three interventions for cognitive dysfunction in post-acute sequelae of SARS-CoV-2 infection (PASC).
Knopman DS; Laskowitz DT; Koltai DC; Charvet LE; Becker JH; Federman AD; Wisnivesky J; Mahncke H; Van Vleet TM; Bateman L; Kim DY; O'Steen A; James M; Silverstein A; Lokhnygina Y; Rich J; Feger BJ; Zimmerman KO
Trials; 2024 May; 25(1):326. PubMed ID: 38755688
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19.
Liu EN; Yang JH; Patel L; Arora J; Gooding A; Ellis R; Graves JS
J Neurol; 2023 Oct; 270(10):4661-4672. PubMed ID: 37493802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
